Ira Pastor

Progress, Potential, and Possibilities Podcast / Show

Science EN ↓ 875 episodes

Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor

Author

Ira Pastor

Category

Science

Podcast website

www.youtube.com

Latest episode

Jul 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Dr. Steven H. Landers, MD, MPH - President & CEO - Hebrew SeniorLife - Redefining The Experience Of Aging 30.11.2023

Send us Fan Mail Dr. Steven H. Landers, MD, MPH is President and CEO of Hebrew SeniorLife ( https://www.hebrewseniorlife.org/services/profiles/steven-h-landers-md-mph ), a nonprofit Harvard Medical School affiliate offering senior living communities and senior health care services for older adults in the Boston metropolitan area. They also conduct aging research that is improving the way we grow o...

Dr. Mitchell Lee, Ph.D. - Chief Executive Officer, Ora Biomedical - A Million Molecule Challenge For Longevity 29.11.2023

Send us Fan Mail Dr. Mitchell Lee, Ph. D. is the Chief Executive Officer of Ora Biomedical ( https://orabiomedical.com/ ), a biotech company developing small molecule therapeutics that extend lifespan and delay chronic illness by targeting the underlying molecular mechanisms of aging. Dr. Lee’s research interests are focused on identifying healthy aging therapeutics, understanding the connections...

Ashley Gaines - Vice President, Head of Breast Cancer Franchise, US Oncology Business Unit, AstraZeneca - Transforming The Diagnosis And Treatment Of Breast Cancer 28.11.2023

Send us Fan Mail Ashley Gaines is Vice President, Head of Breast Cancer Franchise, US Oncology Business Unit, at AstraZeneca ( https://www.astrazeneca-us.com/az-in-us/ashley-gaines.html ) where she is responsible for overseeing commercialization in the US for ENHERTU, TRUQAP and future breast cancer assets and indications. Ashley joined AstraZeneca in 2014 and has led commercial teams across vario...

Dr. Alejandro Dorenbaum, M.D. - Chief Medical Officer, Reneo Pharmaceuticals - Developing Novel Therapies For Patients With Rare Genetic Mitochondrial Diseases 27.11.2023

Send us Fan Mail Dr. Alejandro (Alex) Dorenbaum, M.D., is the Chief Medical Officer of Reneo Pharmaceuticals ( https://reneopharma.com/ ), a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic diseases, including mitochondrial diseases, with significant unmet medical needs. Previously, Dr. Dorenbaum was Chief Medical Officer at Allakos, wher...

Dr. Julia Allen - Chief Scientist, Autonomy and ArtificiaI Intelligence, Saab - Creating Smarter Products And Solutions Through Artificial Intelligence 23.11.2023

Send us Fan Mail Dr. Julia Allen is Chief Scientist, Autonomy and Artificial Intelligence, at Saab ( https://www.saab.com/ ) where her team’s primary focus is developing AI technologies to support the organization’s customers across all U.S. Department of Defense branches, helping government research and development leaders take on their hardest challenges. Saab serves the global market with world...

Dr. Nigel McCracken, Ph.D. - Chief Operating Officer, Virax Biolabs - T-Cell Testing For Detecting Immune Responses & Diagnosing Viral Diseases 22.11.2023

Send us Fan Mail Dr. Nigel McCracken, Ph. D. is Chief Operating Officer of Virax Biolabs ( https://www.viraxbiolabs.com/ ), an innovative diagnostics and detection biotech company developing a game-changing T-Cell immunology technology platform to provide early diagnosis for post viral syndromes, and indications associated with chronic inflammation and T cell exhaustion, to enable early treatment...

Dr. Josh Denny, M.D., M.S. - CEO, All of Us Research Program, National Institutes of Health (NIH) - Accelerating Health Research And Medical Breakthroughs, Enabling Individualized Prevention, Treatment And Care 21.11.2023

Send us Fan Mail Dr. Josh Denny, M.D., M.S., is the Chief Executive Officer (CEO) of the National Institutes of Health’s All of Us Research Program ( https://allofus.nih.gov/about/who-we-are/joshua-denny ), an initiative that seeks to enroll at least one million diverse participants to build an indispensable resource that accelerates precision medicine for all populations. Dr. Denny has been invol...

Jerry McLaughlin - Chief Executive Officer and Board Member - Life Biosciences, Inc. - Developing Novel Therapies To Extend Healthy Human Lifespan 20.11.2023

Send us Fan Mail Jerry McLaughlin is Chief Executive Officer and Board Member of Life Biosciences, Inc. ( https://www.lifebiosciences.com/ ), a private biotechnology company dedicated to developing novel therapies to extend healthy human lifespan, pursuing a platform approach to develop therapeutics that can prevent, treat, and/or reverse multiple aging-related conditions. Jerry has over 30 years...

Christina Tobin - Founder and Chair - Free & Equal Elections Foundation - Opening The Electoral Process For All Candidates 17.11.2023

Send us Fan Mail Christina Tobin is an activist and leader in the election reform and voters’ rights movements. She is the founder and chair of the Free & Equal Elections Foundation ( https://freeandequal.org/ ), and president and chief executive officer of Free & Equal, Inc. Tobin’s non-profit the Free & Equal Elections Foundation leads national, state and local efforts to open the el...

Dr. Elizabeth Garner, MD, MPH - Chief Scientific Officer, U.S., Ferring Pharmaceuticals - President American Medical Women's Association (AMWA) - The Future Of Women's Health, Fertility And Fem-Tech 08.11.2023

Send us Fan Mail Dr. Elizabeth Garner, MD, MPH, ( https://ferringusa.com/?team=elizabeth-garner-md-mph ) is Chief Scientific Officer, U.S., Ferring Pharmaceuticals, a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and maternal health, as well as in specialty areas wit...

Dr. Wade Blair, PhD - Head of Virology & Vaccine Discovery, Vaccines & Immune Therapies, AstraZeneca - Discovering And Developing Novel Anti-Viral Therapeutic Interventions 06.11.2023

Send us Fan Mail Dr. Wade Blair, Ph. D. is Head of Virology and Vaccine Discovery, Vaccines and Immune Therapies, at AstraZeneca ( https://www.astrazeneca.com/ ). Dr. Blair did his Ph. D. in Microbiology at University of California, Irvine - College of Medicine, did Postdoctoral Research at Duke University in HIV, and has held positions of increasing responsibility across both therapeutic and vacc...

Dr. Rolland Carlson, PhD - CEO, Immunexpress, Inc. - Improving Outcomes For Patients With Sepsis 01.11.2023

Send us Fan Mail Dr. Rolland Carlson, PhD, is Chief Executive Officer of Immunexpress, Inc. ( https://immunexpress.com/company-overview/ ), a Seattle-based molecular diagnostic company committed to improving outcomes for patients suspected of having sepsis. Immunexpress' FDA cleared SeptiCyte™ technology rapidly quantifies, directly from whole blood, specific molecular markers from the patien...

Saed Nuh Ahmed - Chairman, Medicine Regulatory Authority, Ministry of Health Development - Somaliland - Regulatory Affairs, Pharmacovigilance And Pandemic Response 30.10.2023

Send us Fan Mail Saed Nuh Ahmed, MPH, B.Pharm. is Chairman of the Medicines Regulatory Authority, Ministry of Health Development (MoHD), of Somaliland ( https://mohd.govsomaliland.org/ ) and National COVID-19 Vaccination Coordinator. Saed has also served a a member of the Antimicrobial Resistance (AMR) Commission of the International Pharmaceutical Federation ( https://www.fip.org/antimicrobial-re...

Dr. Sofiya Milman, MD, MS - Director, Human Longevity Studies, Institute for Aging Research, Albert Einstein College of Medicine 25.10.2023

Send us Fan Mail Dr. Sofiya Milman, MD, MS ( https://www.einsteinmed.edu/faculty/12865/sofiya-milman/ ) is an Associate Professor of Medicine in the Division of Endocrinology and Geriatrics, and is the Director of Human Longevity Studies at the Institute for Aging Research, at Albert Einstein College of Medicine. Dr. Milman’s research focuses on a unique population of centenarians and their famili...

Pete O’Heeron - CEO, FibroBiologics - Developing & Commercializing Fibroblast Cell-Based Therapies 24.10.2023

Send us Fan Mail Pete O’Heeron, MSHA, is the CEO of FibroBiologics ( https://fibrobiologics.com/ ), a biopharmaceutical company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. Mr. O’Heeron has over 25 years of medical technology and biotech development experience and brings together the resources necessary to commercialize uni...

Kaushik Gune - Head of Healthcare (US), Huma - Digital-First Care For Longer, Fuller Lives 20.10.2023

Send us Fan Mail Kaushik Gune is Head of Healthcare (US) for Huma ( https://www.huma.com/ ), a global digital health technology company that uses AI to advance a digital-first care delivery and research model to help people live longer, fuller lives. Huma's regulated Software as a Medical Device is the only disease agnostic platform to hold both EU MDR (The European Union Medical Device Regul...

Marcie Finney, Cleveland Cord Blood Center, & Dr. Frances Verter, Ph.D., Parent's Guide to Cord Blood Foundation - Innovating, Advocating & Advancing Cord Blood R&D 19.10.2023

Send us Fan Mail Marcie Finney is the Executive Director of the Cleveland Cord Blood Center ( https://clevelandcordblood.org/about-us/leadership/ ) where her responsibilities include strategic planning, finance, administration and quality product development. With an extensive background in the field of cord blood, she spent over 10 years at Case Western Reserve University where she participated i...

Dr. Carl Dieffenbach - Director, Division of AIDS, NIAID, U.S. National Institutes of Health - Creating An “AIDS-Free Generation" And Ending The Epidemic 12.10.2023

Send us Fan Mail Dr. Carl Dieffenbach ( https://www.niaid.nih.gov/about/carl-w-dieffenbach-phd ) is the Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health. Dr. Dieffenbach has oversight of a global HIV/AIDS research portfolio of over one billion dollars and a staff of over 150 federal employees and is respon...

Leslie Orne - President & CEO - Trinity Life Sciences - Strategic Innovation For Pharmaceutical Commercialization, Access, Coverage And Pricing 06.10.2023

Send us Fan Mail Leslie Orne ( https://trinitylifesciences.com/our-experts/leslie-sandberg-orne/ ) is President & Chief Executive Officer of Trinity Life Sciences, a fast-growing consultancy in the healthcare industry and with a reputation as a trusted strategic partner, delivering evidence-based solutions for the life sciences, including: advisory services, insights and analytics, and technol...

Dr. Malin Grape, Ph.D. - Ambassador on Antimicrobial Resistance, Ministry for Health and Social Affairs, Sweden - Strengthening Global Efforts Against Antimicrobial Resistance 06.10.2023

Send us Fan Mail Dr. Malin Grape, Ph. D. is Ambassador on Antimicrobial Resistance, at the Ministry of Health and Social Affairs of Sweden ( https://www.government.se/government-of-sweden/ministry-of-health-and-social-affairs/ ), a role she has held since March 2022 ( https://www.government.se/articles/2022/10/swedens-ambassador-for-work-against-antimicrobial-resistance/ ). Previous to this positi...

Dr. Alex Colville, Ph.D. - Co-Founder and General Partner - age1 - Venture Investing To Catalyze The Next Generation Of Founder-Led, Longevity Biotech Companies 03.10.2023

Send us Fan Mail Dr. Alex Colville, Ph. D. is Co-Founder and General Partner of age1 ( https://age1.com/ ), a venture capital firm focused on catalyzing the next generation of founder-led, longevity biotech companies, with a strategy of building a community of visionaries advancing new therapeutics, tools, and technologies targeting aging and age-related diseases. With a recent initial closing of...

Linda Burger - Director, Office of Research and Technology Applications - U.S. National Security Agency (NSA) - Advancing Breakthroughs At The Intersection Of National Security And Economic Development 28.09.2023

Send us Fan Mail Linda Burger is Director of the Office of Research and Technology Applications ( https://www.nsa.gov/Research/Technology-Transfer-Program/Research-and-Technology-Applications/ ), at the U.S. National Security Agency (NSA) where her team is focused on accelerating and improving the exchange of expertise between NSA and other government agencies, academia, and industry, to ultimatel...

Dr. Ruth Tal-Singer, Ph.D. & Dr. Scott M. White, M.D. - ENA Respiratory - Transforming The Treatment & Prevention Of Respiratory Viral Infections Via Innate Immune Modulation 27.09.2023

Send us Fan Mail ENA Respiratory ( https://enarespiratory.com/ ) is a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, including the elderly, those with chronic lung conditions and individuals with occupational risk (e.g. first responders, military or essential services...

Dr. Marco Quarta, Ph.D. - Co-Founder and CEO - Rubedo Life Sciences; Discovering And Developing Medicines To Keep You Biologically Young 22.09.2023

Send us Fan Mail Dr. Marco Quarta, Ph. D. is Co-Founder and CEO of Rubedo Life Sciences ( https://www.rubedolife.com/ ), a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. The company's proprietary ALEMBIC™ drug discovery platform has engineered novel first-in-class small molecules designed to s...

Dr. Peter M. Fleischut, MD - Group Senior Vice President And Chief Information & Transformation Officer, NewYork-Presbyterian Hospital - Leveraging Technology For Innovative, Patient-Centered Clinical Care 21.09.2023

Send us Fan Mail Dr. Peter M. Fleischut, M.D., is Group Senior Vice President and Chief Information and Transformation Officer at NewYork-Presbyterian ( https://www.nyp.org/ )where he oversees the strategic vision and management of enterprise information technology, lab operations, pharmacy operations, innovation, data and analytics, artificial intelligence, telemedicine, and cybersecurity. Dr. Fl...

Listen to the Progress, Potential, and Possibilities Podcast / Show podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.